Oxford Lane Capital (OXLC) Q2 2027 earnings review

Oxford Lane halves its payout and its book value shrinks

The loan market recovered this quarter, but the cash Oxford Lane's holdings pay out shrank again. The fund owns the equity slices of bundled corporate loans, the parts paid last, and that cash is what it lives on. Core net investment income fell to $0.68 a share from $0.95, and the board halved the monthly payment from January. Book value per share ended September at $9.95.

At a glance
Net asset value per share$9.95 $10.74 in June
Core net investment income per share$0.68 $0.95 in June
Total investment income$82.2 million down 36% from a year ago
Monthly payment to shareholders, January-MarchHalved to $0.10 $0.20 since April

โš–๏ธ Verdict: ๐Ÿ”ด Bearish

The case got worse. The cash Oxford Lane's deals pay it dropped by more than a quarter in three months, and the board halved the monthly payment. One consolation: fewer loans inside those deals defaulted, and resets pushed the portfolio's reinvestment dates further out.

The question now is whether the cash these deals pay has reached its bottom. Cohen traces the weakness to money flows and sentiment, which can turn; the other reading is that tight loan spreads have permanently thinned the margin the equity earns. February's cash yield settles it.

๐Ÿ‚ Bull Case

๐ŸŸข persistent PRODUCT

Resets Extend the Reinvestment Period to 2030

Oxford Lane owns the equity slices of collateralized loan obligations, or CLOs: funds that borrow money to buy corporate loans and pay their equity holders last. Every CLO has a reinvestment period, the years in which its manager may replace loans as borrowers repay them.

Managing director Joe Kupka said the fund led or joined resets and refinancings in the quarter, "taking advantage of tighter liability spreads to lower the cost of funding and lengthen the weighted average reinvestment period". That average now ends in January 2030, against November 2029 in June. It has moved further out in each of the past five quarters, so these managers keep the right to trade their loan pools for longer.

What to watch: the reinvestment date in the February report, set beside the cash yield on the equity portfolio. A reset lowers what a CLO pays its own lenders, so a yield that keeps sliding anyway would mean cheaper funding is not reaching the equity.

๐ŸŸข strengthening MACRO

Loan Defaults Inside the Pools Fell by Half

The loans sitting inside these CLOs are ordinary corporate borrowings, and when one of them defaults the cash reaching the equity slice shrinks. Kupka put the 12-month default rate for the loan index at 0.55% at the end of September, down from 0.97% in June. In March it stood at 1.4%.

Prices moved the same way. Loans held inside the pools carried an average price of 95.38%, against 95.09% three months earlier, and no single borrower accounts for more than 0.58% of the collateral. Kupka also warned that "out-of-court restructurings, exchanges and subpar buybacks, which are not captured in the cited default rate, remain elevated", so part of the stress never shows up in that figure.

What to watch: the default rate and the diverted-cash figure in February, read together. Fewer defaults alongside more diverted cash would say the damage comes from thin interest margins inside the deals rather than from borrowers failing.

๐Ÿป Bear Case

๐Ÿ”ด๐Ÿ”ด persistent GROWTH contradicts narrative

Book Value Fell While the Loan Market Improved

Net asset value per share is what the portfolio would fetch, divided by the shares outstanding, and for this fund it is half the scorecard. It ended September at $9.95, after $10.74 in June. Oxford Lane wrote down holdings it still owns and crystallised losses on holdings it sold.

Chief executive Jonathan Cohen has explained earlier falls by pointing at the market, and this quarter the market went the other way. Kupka reported "an approximate 5-point increase in median U.S. CLO equity net asset values" as loan prices rose. The fund's own book value shrank regardless, which is the part management did not reconcile.

  • Net asset value per share: $9.95, from $10.74 in June
  • A year ago: $19.19, so down 48%
  • Writedowns on holdings still owned: $43.8 million
  • Losses crystallised on sales: $22.6 million
  • CLO equity carried at about half its original cost, by our math

What to watch: the December net asset value against the median move in CLO equity marks. Falling behind a rising market for a second quarter would place the problem inside this portfolio rather than in prices.

๐Ÿ”ด๐Ÿ”ด strengthening CASH

Cash From the Loan Deals Dropped Again

Core net investment income counts the cash the CLO equity holdings actually hand over, which is why it, and not the accounting profit, pays the monthly cheque. It reached $66.4 million, or $0.68 a share. Three months earlier the fund collected $93.4 million, and a year earlier $120.0 million.

Almost the whole fall sits in one line. The cash adjustment that separates the two income measures came to $18.6 million against $43.2 million in June, which is nine-tenths of the quarterly decline by our math. The cash yield on the equity portfolio dropped to 12.4% from 16.3%.

Cohen pinned the cause on loan pricing rather than on credit: "Leveraged loan prices have not been depressed." Strong loan prices leave thin loan spreads, and the median spread inside these pools eased again, to 3.00% from 3.02%. Kupka said "Accumulated spread compression has weighed on cash flows", and cited Barclays counting this year's CLO equity payments as the lowest since the financial crisis.

What to watch: the cash yield in February. Another step down would show that deals reset during 2026 still pay their equity less, whatever the loan market does.

๐Ÿ”ด๐Ÿ”ด strengthening CAPITAL ALLOCATION

The Monthly Payment Is Halved Again

Shareholders here are paid every month, and that cheque is the reason most of them own the fund at all. The board has set 10 cents a share for January, February and March, half the 20 cents it has paid since April. In the middle of last year the rate was 45 cents.

Tax rules force the fund's hand in one direction only: it must distribute at least 90% of its taxable income each year to keep its status, and the fiscal year ends in March. Management has said before that a catch-up payment can follow, and the company warns that "neither GAAP NII nor Core NII should be relied upon as indicators of our taxable income".

The smaller cheque is at least earned. Accounting net investment income of 49 cents a share covers the 30 cents the quarter will now pay. But that cover arrived because the board cut the payment, not because the fund earned more, and each of the past three declarations has moved the rate lower.

What to watch: the declaration in late January for the June quarter. A fourth reduction would tell shareholders the board does not yet trust the cash coming out of these deals to hold.

๐Ÿ”ด new MARGIN

Oxford Lane Swaps 5% Notes for 8.25% Preferred

The fund borrows in order to hold a larger portfolio, so the price of that money decides how much income survives for shareholders. On October 2 it repaid $30 million of notes carrying a 5% coupon, and it has told holders "it will redeem the remaining $40.0 million aggregate principal amount of these notes on December 4, 2026".

Three weeks after the first repayment the fund sold 1.6 million more shares of its 8.25% preferred stock, raising $40 million. So the cheapest money is walking out and the dearest is walking in: the average rate across borrowings and preferred stock rises to about 7.7% from 7.4%, by our math, even though the balance owed falls.

Costs matter more as income shrinks. Total expenses absorbed 41.8% of investment income this quarter, against 36.6% a year ago, because income fell faster than the bill did. The portfolio's effective yield is 10.5%, so the margin over funding is thinner than it looks.

What to watch: expenses as a share of investment income in February. Another step up would mean the fund's lenders and preferred holders are taking the benefit the resets were meant to deliver.

๐Ÿ‘“ Other Themes

new MACRO

More New CLOs, Fewer Resets in the Market

The wider market picked up. Kupka counted about $46 billion of new CLOs in the quarter, roughly $12 billion more than in the previous one, while resets and refinancings slowed to about $86 billion. Cohen blamed the weak pricing of CLO equity on "flows of funds and technical factors and supply and demand characteristics" rather than on borrowers.

๐Ÿ’ฒ Other KPIs

Cash diverted by the CLOs (27Q2) $2.8 million
โ‡— accelerating

Up from $1.5 million in June and the highest in five quarters. This is cash the loan deals held back instead of paying Oxford Lane, because they failed their collateral or interest tests. It now equals 3.4% of investment income, so the leak is widening while income shrinks.

Portfolio at fair value (27Q2) $1,583.9 million
โ‡˜ decelerating

Smaller for a fifth straight quarter, down 5.8% in three months and 39.1% in a year. Oxford Lane again sold more than it bought, taking in $31.2 million and spending $18.7 million. It holds 280 separate positions now. A smaller portfolio earns less, which is why income keeps sliding.

๐Ÿ”ฎ Guidance

Monthly common distribution, January-March 2027 $0.10 per share per month
๐Ÿ ‡ cut from $0.20 per share per month (October-December 2026)
โ‡˜ decelerating

Cut. The board halved the monthly payment to 10 cents a share for January, February and March. The quarter therefore pays 30 cents, against 60 cents in each of the three before it. It is the third reduction in little over a year. Net investment income of 49 cents a share covers the new rate.

Monthly preferred dividends, December 2026 - February 2027 $0.125, $0.1484375 and $0.171875 per share per month
๐Ÿ † unchanged from $0.125, $0.1484375 and $0.171875 per share per month (September-November 2026)
โ‡’ stable

Unchanged. The fund will pay the same fixed dividends on its three preferred series for three more months. The rates run from 6.00% to 8.25% of the price at which each share can be redeemed, and none of them can be set lower. In October the fund sold $40 million more of the dearest series, so this cost rises from here.

CLO equity awaiting a first payment $7.5 million at original cost, all expected to pay by December 31, 2026
๐Ÿ … raised from $1.0 million expected by December 31, 2026
โ‡˜ decelerating

Raised, and still small. Oxford Lane holds $7.5 million of CLO equity at cost that has yet to pay it anything, and all of it should start by the end of December. A year ago that queue held $366 million of future income. Nothing at all is scheduled to begin paying after December, so the fund must buy to refill it.

Redemption of the 5.00% notes due 2027 Remaining $40.0 million to be redeemed on December 4, 2026
โ‡˜ decelerating

New. Having repaid $30 million of these notes in October, the fund will retire the rest in December and the series disappears. That removes its cheapest money, at a 5% coupon. Borrowings and preferred stock then fall to about $640 million, by our math, from $669.9 million at the end of September.

โ“ Key Questions

Will shareholders get a catch-up payment in March?

Tax rules oblige Oxford Lane to distribute at least 90% of its taxable income, and its year ends in March. With the monthly cheque halved, shareholders still do not know whether a one-off payment follows.

What discount did the new purchases carry?

Cohen sees "interesting and even compelling opportunities now within that market for this asset class", yet the fund spent only $18.7 million and sold $31.2 million. The prices paid, against the marks, would show whether the opportunity is real.

How many deals now fail their cash tests?

Diverted cash nearly doubled in three months. The fund publishes a cushion for each deal but no count of how many have slipped below their limits, so the size of the problem stays hidden.

What share of new CLOs comes from captive funds?

Management said three quarters ago that most new issues could come from funds willing to accept lower returns, which thins what equity holders earn. New issuance has since picked up, with no figure offered.

Why did book value fall as marks rose?

Kupka counted a 5-point rise in median CLO equity values during the quarter, while Oxford Lane's own net asset value per share fell 7.4%. Shareholders deserve to know which holdings moved the other way.